SCHEMBL10000742

SCHEMBL10000742

Cc1cc(/C=C/C(=O)OC(C(=O)O)C(O)C(=O)O)ccc1O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 2/20 0.79
TDP1 Q9NUW8 4/20 0.65
HSD17B10 Q99714 3/20 0.65
TP53 P04637 1/20 0.65
ALOX15 P16050 1/20 0.65
BACE1 P56817 1/20 0.48
KDM4E B2RXH2 3/20 0.47
MAPT P10636 3/20 0.47
TTR P02766 3/20 0.47
APP P05067 3/20 0.47
POLB P06746 2/20 0.47
GAA P10253 2/20 0.47
HPGD P15428 2/20 0.47
RECQL P46063 2/20 0.47
MMP1 P03956 2/20 0.47
AKR1B1 P15121 2/20 0.47
CYP1A2 P05177 1/20 0.47
KDM1A O60341 1/20 0.47
USP2 O75604 1/20 0.47
JUN P05412 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Caffeoyltartaric Acid SCHEMBL962483 0.88 SRC (1.00) SRCTDP1HSD17B10TP53ALOX15
Caftaric Acid SCHEMBL29352215 0.88 SRC (1.00) SRCTDP1HSD17B10TP53ALOX15
Caffeoyltartaric Acid SCHEMBL30272738 0.88 SRC (1.00) SRCTDP1HSD17B10TP53ALOX15
Caffeoyltartaric Acid SCHEMBL16426391 0.88 SRC (1.00) SRCTDP1HSD17B10TP53ALOX15
Caffeoyltartaric Acid SCHEMBL826444 0.88 SRC (1.00) SRCTDP1HSD17B10TP53ALOX15
Caffeoyltartaric Acid SCHEMBL24725181 0.88 SRC (1.00) SRCTDP1HSD17B10TP53ALOX15
Caftaric Acid SCHEMBL16426394 0.88 SRC (1.00) SRCTDP1HSD17B10TP53ALOX15
SCHEMBL10028945 0.85 SRC (0.75) SRCTDP1HSD17B10TP53ALOX15
SCHEMBL5597077 0.85 SRC (0.75) SRCTDP1HSD17B10TP53ALOX15
SCHEMBL2364605 0.81 SRC (0.72) SRCTDP1HSD17B10TP53ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9492416-B2 Use of caftaric acid and lactic bacterium in food supplement for regulating skin pigmentation NESTEC S.A. (CH) 2016-11-15 US disclosed
US-20130095074-A1 USE OF CAFTARIC ACID AND LACTIC BACTERIUM IN FOOD SUPPLEMENT FOR REGULATING SKIN PIGMENTATION L'OREAL (FR) 2013-04-18 US disclosed
US-20120020926-A1 COMPOSITION COMPRISING CAFTARIC ACID AND/OR DERIVATIVES THEREOF NESTEC S.A. (CH) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130095074-A1 USE OF CAFTARIC ACID AND LACTIC BACTERIUM IN FOOD SUPPLEMENT FOR REGULATING SKIN PIGMENTATION TYR, LCT, GAA SRC 968/4885TDP1 252/4885HSD17B10 595/4885
US-20120020926-A1 COMPOSITION COMPRISING CAFTARIC ACID AND/OR DERIVATIVES THEREOF LCT, CA1, CA6 SRC 1402/4885TDP1 266/4885HSD17B10 368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.